FrancophonIA/ELRC3.0 huggingface dataset:
English: After intravenous bolus administration of ceftriaxone 500 mg and 1 g, mean peak plasma ceftriaxone levels are approximately 120 and 200 mg/l respectively.
Maltese: Assorbiment Wara għoti bolus fil-vini ta' 500 mg u 1 g ceftriaxone, il-livelli massimi medji ta' ceftriaxone fil plażma huma bejn wieħed u ieħor 120 u 200 mg/l rispettivament.
English: Pharmacotherapeutic group: Antibacterials for systemic use, Third-generation cephalosporins, ATC code: J01DD04.
Maltese: Antibatteriċi għall-użu sistemiku, Cephalosporins tat-tielet ġenerazzjoni, Kodiċi ATC:
English: The volume of distribution of ceftriaxone is 7 - 12 l. Concentrations well above the minimal inhibitory concentrations of most relevant pathogens are detectable in tissue including lung, heart, biliary tract/liver, tonsil, middle ear and nasal mucosa, bone, and in cerebrospinal, pleural, prostatic and synovial fluids.
Maltese: Konċentrazzjonijiet ferm ogħla mill konċentrazzjonijiet inibitorji minimi tal-biċċa l-kbira ta' patoġeni rilevanti huma osservati f'tessuti inkluż il-pulmun, qalb, apparat biljari/fwied, tunsilli, widna tan-nofs u mukuża tal-imnieħer, għadam,
English: Rocephin can affect the results of urine tests for sugar and a blood test known as the Coombs test.
Maltese: Rocephin jista' jaffettwa r-riżultati ta' testijiet tal-awrina għaz-zokkor u ta' test tad-demm magħruf bħala t-test ta' Coombs.
English: • Pruritis (itching).
Maltese: • Prurite (ħakk).
English: There is conflicting evidence regarding a potential increase in renal toxicity of aminoglycosides when used with cephalosporins.
Maltese: Hemm evidenza konfliġġenti dwar żieda potenzjali fit-tossiċità renali ta' aminoglycosides meta jintużaw flimkien ma' cephalosporins.
English: Mean peak ceftriaxone concentrations in CSF in patients with bacterial meningitis are reported to be up to 25 % of plasma levels compared to 2 % of plasma levels in patients with uninflamed meninges.
Maltese: Il konċentrazzjonijiet massimi medji ta' ceftriaxone fis-CSF f'pazjenti b'meninġite kkawżata minn batterja huma rrappurtati li huma sa 25 % tal-livelli fil-plażma meta mqabbla ma' 2 % tal-livelli fil plażma f'pazjenti b'meninġi mhux infjammati.
English: • You have had a sudden or severe allergic reaction to penicillin or similar antibiotics (such as cephalosporins, carbapenems or monobactams).
Maltese: • Kellek reazzjoni allerġika f'daqqa jew severa għal penicillin jew għal antibijotiċi simili (bħal cephalosporins, carbapenems jew monobactams).
English: Haematuria Glycosuria
Maltese: Ematurja Glukosurja
English: In vitro studies using adult and neonatal plasma from umbilical cord blood demonstrated that neonates have an increased risk of precipitation of ceftriaxone-calcium (see sections 4.2, 4.3, 4.4, 4.8 and 6.2).
Maltese: Studji in vitro bl-użu ta' plażma tal-adulti u tat-trabi tat-twelid minn demm tal-kurdun taż-żokra wrew li trabi tat-twelid għandhom riskju akbar ta' preċipitazzjoni ta' ceftriaxone-kalċju (ara sezzjonijiet 4.2, 4.3, 4.4, 4.8 u 6.2).
English: Oliguria Renal precipitation (reversible)
Maltese: Preċipitazzjoni fil-kliewi (riversibbli)
English: Studies have shown that ceftriaxone, like some other cephalosporins, can displace bilirubin from serum albumin.
Maltese: Studji wrew li ceftriaxone, bħal xi cephalosporins oħra, jista' jneħħi l-bilirubina minn mal-albumina fis-serum.
English: Very common (≥ 1/10)
Maltese: Komuni ħafna (≥ 1/10)
English: See information in the Summary of Product Characteristics of lidocaine, especially contraindications.
Maltese: Sommarju tal-Karatteristiċi tal-Prodott ta' lidocaine, speċjalment kontraindikazzjonijiet.
English: Coombs test false positiveb
Maltese: Test ta' Coombs pożittiv falzb Test għal galaktosemija pożittiv falzb
English: In patients treated with ceftriaxone, the Coombs' test may lead to false-positive test results.
Maltese: F'pazjenti kkurati b'ceftriaxone, it-test ta' Coombs jista' jwassal għal riżultati pożittivi foloz.
English: The most frequently reported adverse reactions for ceftriaxone are eosinophilia, leucopenia, thrombocytopenia, diarrhoea, rash, and hepatic enzymes increased.
Maltese: tromboċitopenija, dijarea, raxx, u żieda fl-enzimi epatiċi.
English: The generally recommended doses are 500 mg-1 g once daily increased to 2 g once daily for neurosyphilis for 10-14 days.
Maltese: Id-dożi li ġeneralment jiġu rrakkomandati huma 500 mg-1 g darba kuljum li tiżdied għal 2 g darba kuljum għal newrosifilide għal 10-14-il ġurnata.
English: 50 - 60 % of ceftriaxone is excreted unchanged in the urine, primarily by glomerular filtration, while 40 - 50 % is excreted unchanged in the bile.
Maltese: primarjament permezz ta' filtrazzjoni mill-glomeruli, filwaqt li 40 - 50 % jitneħħa mhux mibdul filbili.
English: • Kidney problems caused by deposits of calcium ceftriaxone.
Maltese: • Problemi fil-kliewi kkawżati minn depożiti ta' ceftriaxone-kalċju.
English: + Resistance rates >50% in at least one region % ESBL producing strains are always resistant
Maltese: + Rati ta' reżistenza ta' >50% f'mill-inqas reġjun wieħed % Rażeż li jipproduċu ESBL dejjem huma reżistenti
English: Ceftriaxone is contraindicated in neonates (≤ 28 days) if they require (or are expected to require) treatment with calcium-containing intravenous solutions, including continuous calcium-containing infusions such as parenteral nutrition, because of the risk of precipitation of ceftriaxone-calcium (see section 4.3).
Maltese: Ceftriaxone huwa kontraindikat fi trabi tat-twelid (≤ 28 ġurnata) jekk dawn ikunu jeħtieġu (jew huma mistennija li jeħtieġu) kura b'soluzzjonijiet fil-vini li jkun fihom il-kalċju, inkluż infużjonijiet kontinwi li fihom il-kalċju bħal nutriment parenterali, minħabba r-riskju ta' preċipitazzjoni ta' ceftriaxone-kalċju (ara sezzjoni 4.3).
English: Anaerobes
Maltese: Anaerobiċi
English: • Difficulty in breathing (bronchospasm).
Maltese: • Diffikultà biex tieħu n-nifs (bronkospażmu).
English: The generally recommended dose is 50 mg/kg once daily for 10-14 days.
Maltese: Id-doża li ġeneralment tiġi rrakkomandata hija 50 mg/kg darba kuljum għal 10-14 il-ġurnata.
English: Ceftriaxone (as Ceftriaxone Sodium)
Maltese: ceftriaxone (bħala ceftriaxone sodium) Mnejn jingħata:
English: Headache Dizziness
Maltese: Edima Sirdat
English: Ceftriaxone-calcium salt precipitation
Maltese: Preċipitazzjoni tal-melħ ceftriaxone-kalċju
English: Treponema pallidum
Maltese: Popolazzjoni pedjatrika
English: • 20 - 50 mg Rocephin for each kg of the child's body weight once a day depending on the severity and type of infection.
Maltese: • 20 - 50 mg Rocephin għal kull kg ta' piż tal-ġisem tat-tarbija darba kuljum skont is-severità u ttip ta' infezzjoni.
English: Hypersensitivity to ceftriaxone, to any other cephalosporin or to any of the excipients listed in section 6.1.
Maltese: Sensittività eċċessiva għal ceftriaxone, għal kwalunkwe cephalosporin ieħor jew għal kwalunkwe wieћed mill-eċċipjenti elenkati fis-sezzjoni 6.1.
English: 2 g Powder for Solution for Infusion Belgium, Luxembourg: Rocephine Denmark, Iceland, Sweden: Rocephalin Germany, Greece, Malta, Netherlands, Portugal, Romania: Rocephin Italy: Rocefin
Maltese: Il-Ġermanja, il-Greċja, Malta, l-Olanda, il-Portugall, ir-Rumanija:
English: • Inflammation of the large bowel (colon).
Maltese: • Infjammazzjoni tal-musrana l-kbira (kolon).
English: 2 g powder for solution for infusion Intravenous use
Maltese: 2 g Trab għal Soluzzjoni għall-Infużjoni
English: Non enzymatic methods for glucose determination false positiveb a Based on post-marketing reports.
Maltese: Metodi mhux enzimatiċi għad determinazzjoni ta' glucose pożittivi folozb a Ibbażat fuq rapporti ta' wara t-tqegħid fis-suq.
English: Indications for adults and children over 12 years of age (≥ 50 kg) that require specific dosage schedules:
Maltese: Indikazzjonijiet għall-adulti u tfal b'età 'l fuq minn 12-il sena (≥ 50 kg) li jeħtieġu skedi speċifiċi ta'
English: In severe renal and hepatic insufficiency, close clinical monitoring for safety and efficacy is advised (see section 4.2).
Maltese: F'insuffiċjenza renali u epatika severa, hija rrakkomandata sorveljanza klinika mill-viċin għas-sigurtà u l-effikaċja (ara sezzjoni 4.2).
English: • Inflammation of the mucus lining of the mouth (stomatitis).
Maltese: • Infjammazzjoni tal-kisja mukuża tal-ħalq (stomatite).
English: Minimum inhibitory concentration (MIC) breakpoints established by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) are as follows:
Maltese: Punti ta' referenza tal-Konċentrazzjoni inibitorja minima (MIC - minimum inhibitory concentration) stabbiliti mill-Kumitat Ewropew dwar l-Ittestjar għas-Suxxettibbiltà Antimikrobika (EUCASTEuropean Committee on Antimicrobial Susceptibility Testing) huma kif ġej:
English: For treatment of acute exacerbations of chronic obstructive pulmonary disease in adults For treatment of disseminated Lyme borreliosis (early (stage II) and late (stage III)) in adults and children including neonates from 15 days of age
Maltese: Għall-kura ta' Lyme borreliosis mifruxa (bikrija (stadju II) u ttardjata (stadju III)) fl-adulti u fit tfal inkluż trabi tat-twelid b'età minn 15-il ġurnata
English: b. Susceptibility inferred from penicillin susceptibility.
Maltese: b. Suxxettibbiltà dedotta mis-suxxettibbiltà għal penicillin. ċ.
English: Interference with Coombs tests may occur, as Rocephin may lead to false-positive test results.
Maltese: Tista' sseħħ interferenza mat-testijiet ta' Coombs, peress li Rocephin jista' jwassal għal riżultati tattest pożittivi foloz.
English: The possibility of sensitisation should be taken into account.
Maltese: Il-possibbiltà ta' sensibilizzazzjoni għandha tiġi kkunsidrata.
English: Not known (Frequency cannot be estimated from the available data)
Maltese: Mhux magħruf (Frekwenza ma tistax tiġi stmata mid-dejta disponibbli)
English: Renal clearance is 5 - 12 ml/min.
Maltese: Ittneħħija mill-kliewi hija ta' 5 - 12 ml/min. 50 - 60 % ta' ceftriaxone jitneħħa mhux mibdul fl-awrina,
English: Acute otitis media For initial treatment of acute otitis media, a single intramuscular dose of Rocephin 50 mg/kg can be given.
Maltese: Għall-kura inizjali ta' otite medja akuta, tista' tingħata doża waħda ġol-muskoli ta' Rocephin 50 mg/kg.
English: Ceftriaxone crosses the placental barrier.
Maltese: Ceftriaxone jgħaddi mill-barriera tal-plaċenta.
English: Susceptibility testing breakpoints
Maltese: Punti ta' referenza għal testijiet ta' suxxettibbiltà
English: • Abnormal kidney function test (blood creatinine increased).
Maltese: • Test tal-funzjoni tal-kliewi mhux normali (żieda tal-krejatinina fid-demm).
English: Treatment of overdose should be symptomatic.
Maltese: Kura ta' doża eċċessiva għandha tkun sintomatika.
English: Severe skin rashes (not known, frequency cannot be estimated from the available data) If you get a severe skin rash, tell a doctor straight away.
Maltese: Reazzjonijiet allerġiċi severi (mhux magħrufa, frekwenza ma tistax tiġi stmata mid-dejta disponibbli)
English: As with all beta-lactam antibacterial agents, serious and occasionally fatal hypersensitivity reactions have been reported (see section 4.8).
Maltese: Bħal b'kull sustanza antibatterika beta-lactam, kienu rrappurtati reazzjonijiet ta' sensittività eċċessiva serji u xi kultant fatali (ara sezzjoni 4.8).
English: Precipitations of ceftriaxone-calcium salt have been observed in lung and kidneys post-mortem.
Maltese: Preċipitazzjonijiet tal-melħ ceftriaxone-kalċju kienu osservati fil pulmun u l-kliewi post-mortem.
English: For pre-operative prophylaxis of surgical site infections, ceftriaxone should be administered 30-90 minutes prior to surgery.
Maltese: 30 - 90 minuta qabel il-kirurġija.
English: Shadows, which have been mistaken for gallstones, have been detected on sonograms of the gallbladder and have been observed more frequently at ceftriaxone doses of 1 g per day and above.
Maltese: Dellijiet, li ġew żbaljati ma' ġebel fil-marrara, kienu osservati fuq sonogrammi tal-marrara u kienu osservati b'mod aktar frekwenti b'dożi ta' ceftriaxone ta' 1 g kuljum u aktar.
English: In neonates, intravenous doses should be given over 60 minutes to reduce the potential risk of bilirubin encephalopathy (see section 4.3 and 4.4).
Maltese: Fi trabi tat-twelid, dożi fil-vini għandhom jingħataw fuq medda ta' 60 minuta biex jitnaqqas ir-riskju potenzjali ta' enċefalopatija kkawżata minn bilirubin (ara sezzjoni 4.3 u 4.4).
English: The relatively modest increase in half-life in renal impairment is explained by a compensatory increase in non-renal clearance, resulting from a decrease in protein binding and corresponding increase in non-renal clearance of total ceftriaxone.
Maltese: Iż-żieda relattivament żgħira fil-half-life f'indeboliment renali hija spjegata minn żieda ta' kumpens fit-tneħħija mhux renali, ikkawżata minn tnaqqis fit-twaħħil mal-proteina u ż-żieda korrispondenti fittneħħija mhux renali ta' ceftriaxone totali.
English: Pseudomembranous colitisb
Maltese: Jekk tieqaf tuża Rocephin
English: Alternatively, infusion of TPN solution could be stopped for the period of ceftriaxone infusion and the infusion lines flushed between solutions (see sections 4.3, 4.8, 5.2 and 6.2).
Maltese: B'mod alternattiv, l-infużjoni tas-soluzzjoni tat-TPN tista' titwaqqaf għall-perjodu tal infużjoni ta' ceftriaxone u l-linji tal-infużjoni għandhom jiġu mlaħalħa bejn is-soluzzjonijiet (ara sezzjonijiet 4.3, 4.8, 5.2 u 6.2).
English: Rocephin can cause dizziness.
Maltese: Rocephin jista' jikkawża sturdament.
English: Immune mediated haemolytic anaemia
Maltese: Anemija emolitikab
English: Pruritus
Maltese: Kunjett
English: Cases of renal lithiasis have been reported, which is reversible upon discontinuation of ceftriaxone (see section 4.8).
Maltese: Kienu rrappurtati każijiet ta' litajażi fil-kliewi, li huma riversibbli mal-waqfien ta' ceftriaxone (ara sezzjoni 4.8).
English: Rocephin is contraindicated in premature neonates up to a postmenstrual age of 41 weeks (gestational age + chronological age).
Maltese: ġimgħa (età ta' ġestazzjoni + età kronoloġika).
English: Rocephin and associated names (see Annex I) 2 g Powder for Solution for Infusion Rocephin and associated names (see Annex I) 2 g Powder for Solution for Injection or Infusion Rocephin and associated names (see Annex I) 1 g Powder for Solution for Injection or Infusion Rocephin and associated names (see Annex I) 1 g Powder and Solvent for Solution for Injection Rocephin and associated names (see Annex I) 500 mg Powder and Solvent for Solution for Injection Rocephin and associated names (see Annex I) 250 mg Powder and Solvent for Solution for Injection Rocephin and associated names (see Annex I) 250 mg Powder for Solution for Injection
Maltese: 2 g Trab għal Soluzzjoni għall-Infużjoni Rocephin u ismijiet assoċjati (ara Anness I) 2 g Trab għal Soluzzjoni għall-Injezzjoni jew Infużjoni Rocephin u ismijiet assoċjati (ara Anness I) 1 g Trab għal Soluzzjoni għall-Injezzjoni jew Infużjoni Rocephin u ismijiet assoċjati (ara Anness I) 1 g Trab u Solvent għal Soluzzjoni għall-Injezzjoni Rocephin u ismijiet assoċjati (ara Anness I) 500 mg Trab u Solvent għal Soluzzjoni għall-Injezzjoni Rocephin u ismijiet assoċjati (ara Anness I) 250 mg Trab u Solvent għal Soluzzjoni għall-Injezzjoni Rocephin u ismijiet assoċjati (ara Anness I) 250 mg Trab għal Soluzzjoni għall-Injezzjoni
English: Ceftriaxone is contraindicated in: Premature neonates up to a postmenstrual age of 41 weeks (gestational age + chronological age)* Full-term neonates (up to 28 days of age): with hyperbilirubinaemia, jaundice, or who are hypoalbuminaemic or acidotic because these are conditions in which bilirubin binding is likely to be impaired* if they require (or are expected to require) intravenous calcium treatment, or calcium-containing infusions due to the risk of precipitation of a ceftriaxone-calcium salt (see sections 4.4, 4.8 and 6.2).
Maltese: - jekk dawn jeħtieġu (jew huma mistennija li jeħtieġu) kura ta' kalċju fil-vini, jew infużjonijiet li jkun fihom il-kalċju minħabba r-riskju ta' preċipitazzjoni tal-melħ ceftriaxone-kalċju (ara sezzjonijiet 4.4, 4.8 u 6.2).
English: Granulocytopenia Anaemia Coagulopathy
Maltese: Granuloċitopenija Anemija
English: Intra-abdominal infections Complicated urinary tract infections (including pyelonephritis)
Maltese: Infezzjonijiet ikkumplikati fl-apparat tal awrina (inkluż pajelonefrite)
English: France: Rocephine
Maltese: Rocephine
English: Breastfeeding
Maltese: Dijareab
English: Pathogen
Maltese: Rocephalin
English: 1 g Powder and Solvent for Solution for Injection Belgium, France, Luxembourg: Rocephine Denmark, Finland, Iceland, Sweden: Rocephalin
Maltese: Rocephine Id-Danimarka, il-Finlandja, l-Islanda, l-Isvezja:
English: ** Twice daily (12 hourly) administration may be considered where doses greater than 2 g daily are administered.
Maltese: ** Għoti darbtejn kuljum (kull 12-il siegħa) jista' jiġi kkunsidrat meta jingħataw dożi ogħla minn 2 g kuljum.
English: • A secondary infection that may not respond to the antibiotic previously prescribed
Maltese: • Infezzjoni sekondarja li tista' ma tirrispondix għall-antibijotiku li kien preskritt qabel.
English: • hydrolysis by beta-lactamases, including extended-spectrum beta-lactamases (ESBLs),
Maltese: • idrolisi minn beta-lactamases, inkluż beta-lactamases bi spettru estiż (ESBLs - extended spectrum beta-lactamases), carbapenemases u enzimi Amp C li tista' tiġi indotta jew depressa b'mod stabbli f'ċerti speċi ta' batterja aerobika negattiva għal Gram.
English: Rocephin and associated names (see Annex I) 2 g Powder for Solution for Infusion Rocephin and associated names (see Annex I) 2 g Powder for Solution for Injection or Infusion Rocephin and associated names (see Annex I) 1 g Powder for Solution for Injection or Infusion Rocephin and associated names (see Annex I) 1 g Powder and Solvent for Solution for Injection Rocephin and associated names (see Annex I) 500 mg Powder and Solvent for Solution for Injection Rocephin and associated names (see Annex I) 250 mg Powder and Solvent for Solution for Injection Rocephin and associated names (see Annex I) 250 mg Powder for Solution for Injection [See annex I - To be completed nationally]
Maltese: 2 g Trab għal Soluzzjoni għall-Infużjoni Rocephin u ismijiet assoċjati (ara Anness I) 2 g Trab għal Soluzzjoni għall-Injezzjoni jew Infużjoni Rocephin u ismijiet assoċjati (ara Anness I) 1 g Trab għal Soluzzjoni għall-Injezzjoni jew infużjoni Rocephin u ismijiet assoċjati (ara Anness I) 1 g Trab u Solvent għal Soluzzjoni għall-Injezzjoni Rocephin u ismijiet assoċjati (ara Anness I) 500 mg Trab u Solvent għal Soluzzjoni għall-Injezzjoni Rocephin u ismijiet assoċjati (ara Anness I) 250 mg Trab u Solvent għal Soluzzjoni għall-Injezzjoni Rocephin u ismijiet assoċjati (ara Anness I) 250 mg Trab għal Soluzzjoni għall-Injezzjoni
English: You are allergic to lidocaine and you are to be given Rocephin as an injection into a muscle.
Maltese: • Inti allerġiku għal lidocaine u għandek tingħata Rocephin bħala injezzjoni ġol-muskoli.
English: Adults, older people and children aged 12 years and over with a body weight greater than or equal to 50 kilograms (kg):
Maltese: Adulti, persuni anzjani u tfal b'età minn 12-il sena 'l fuq b'piż tal-ġisem ta' aktar minn jew ugwali għal 50 kilogramma (kg):
English: • Abnormalities with your white blood cells (such as a decrease of leucocytes and an increase of eosinophils) and platelets (decrease of thrombocytes).
Maltese: • Anormalitajiet fiċ-ċelluli bojod tad-demm (bħal tnaqqis fil-lewkoċiti u żieda fl-esinofili) u plejtlits (tnaqqis ta' tromboċiti).
English: Complicated skin and soft tissue infections Gonorrhoea
Maltese: Infezzjonijiet ikkumplikati tal-ġilda u tat-tessut l-artab Gonorrea
English: As with other beta-lactams, the pharmacokinetic-pharmacodynamic index demonstrating the best correlation with in vivo efficacy is the percentage of the dosing interval that the unbound concentration remains above the minimum inhibitory concentration (MIC) of ceftriaxone for individual target species (i.e. %T > MIC).
Maltese: Bħal b'beta-lactams oħrajn, l-indiċi farmakokinetiku-farmakodinamiku li juri l-aħjar korrelazzjoni mal-effikaċja in vivo huwa l-persentaġġi tal-intervall ta' dożaġġ li fih il-konċentrazzjoni mhux imwaħħla tibqa' 'l fuq mill-konċentrazzjoni inibitorja minima (MIC - minimum inhibitory concentration) ta' ceftriaxone għall-ispeċi mmirati individwali (jiġifieri %T > MIC).
English: The generally recommended doses are 75-100 mg/kg (max 4 g) once daily for 10-14 days.
Maltese: Sifilide Id-dożi li ġeneralment jiġu rrakkomandati huma 75-100 mg/kg (massimu 4 g) darba kuljum għal
English: Rocephin is an antibiotic given to adults and children (including newborn babies).
Maltese: Rocephin huwa antibijotiku li jingħata lill-adulti u lit-tfal (inklużi trabi tat-twelid).
English: Rocephin can be administered by intravenous infusion over at least 30 minutes (preferred route) or by slow intravenous injection over 5 minutes, or by deep intramuscular injection.
Maltese: Rocephin jista' jingħata permezz ta' infużjoni fil-vini fuq mill-inqas 30 minuta (rotta preferuta) jew permezz ta' injezzjoni bil-mod fil-vini fuq medda ta' 5 minuti, jew bħala injezzjoni fil-fond ġolmuskoli.
English: Rocephin 250 mg Powder for Solution for Injection Malta, Netherlands, United Kingdom: Rocephin [See Annex I - To be completed nationally] This leaflet was last revised in <{MM/YYYY}> <{month YYYY}>.
Maltese: Malta, l-Olanda, ir-Renju Unit: Rocephin [Ara Anness I - Biex timtela mill-pajjiż partikolari]
English: Gonorrhoea 500 mg as a single intramuscular dose.
Maltese: 500 mg bħala doża waħda ġol-muskoli.
English: Colitis/Overgrowth of non-susceptible microorganisms Antibacterial agent-associated colitis and pseudo-membranous colitis have been reported with nearly all antibacterial agents, including ceftriaxone, and may range in severity from mild to life-threatening.
Maltese: Kolite/Tkabbir żejjed ta' mikro-organiżmi mhux suxxettibbli Kolite assoċjata ma' sustanzi antibatteriċi u kolite psewdomembrana kienu rrappurtati kważi b'kull sustanza antibatterika, inkluż ceftriaxone, u jistgħu jvarjaw fis-severità minn ħfief sa ta' periklu għallħajja.
English: This should be taken into consideration in patients on a controlled sodium diet.
Maltese: Dan għandu jiġi kkunsidrat f'pazjenti fuq dieta ta' sodium ikkontrollat.
English: Most patients presented with risk factors for biliary stasis and biliary sludge e.g. preceding major therapy, severe illness and total parenteral nutrition.
Maltese: Il-biċċa l-kbira tal-pazjenti kellhom fatturi ta' riskju għal stasi biljari u ħama biljari eż. terapija maġġuri minn qabel, mard sever u nutrizzjoni parenterali totali.
English: From birth to 14 days of age, the levels of free ceftriaxone may be further increased by factors such as reduced glomerular filtration and altered protein binding.
Maltese: Mit-twelid sal-età ta' 14-il ġuranta, il-livelli ta' ceftriaxone ħieles jistgħu jiżdiedu aktar permezz ta' fatturi bħall-filtrazzjoni glomerulari mnaqqsa u bidla fit-twaħħil mal-proteini.
English: Community acquired pneumonia Acute exacerbations of chronic obstructive pulmonary disease
Maltese: Darba kuljum Pulmonite miksuba fil-komunità Irkadar akut tal-marda ostruttiva kronika tal-pulmun Infezzjonijiet intra-addominali
English: Only in cases of preterminal renal failure (creatinine clearance < 10 ml/min) should the ceftriaxone dosage not exceed 2 g daily.
Maltese: F'każijiet ta' insuffiċjenza renali preterminali (tneħħija tal krejatinina ta' < 10 ml/min) biss id-dożaġġ ta' ceftriaxone m'għandux jaqbeż 2 g kuljum.
English: a. Susceptibility inferred from cefoxitin susceptibility.
Maltese: Suxxettibbiltà dedotta mis-suxxettibbiltà għal cefoxitin.
English: Therefore, ceftriaxone and calcium-containing solutions must not be mixed or administered simultaneously (see sections 4.3, 4.4 and 6.2).
Maltese: Għalhekk, ceftriaxone u soluzzjonijiet li fihom il-kalċju m'għandhomx jitħalltu jew jingħataw flimkien (ara sezzjonijiet 4.3, 4.4 u 6.2).